UK markets close in 1 hour 53 minutes

Amphastar Pharmaceuticals, Inc. (29A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
38.61+0.16 (+0.42%)
As of 08:16AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
154,690
137,545
91,386
62,116
1,403
-
Depreciation & amortisation
48,344
41,777
28,275
26,533
25,180
-
Deferred income taxes
-
-13,737
-15,751
4,209
1,123
-
Stock-based compensation
21,491
20,242
17,860
18,687
20,498
-
Change in working capital
-31,276
-24,209
-32,177
-1,951
11,301
-
Accounts receivable
-37,491
-26,086
-10,132
-14,921
-20,160
-
Inventory
-11,987
-1,724
-11,746
1,258
15,297
-
Accounts payable
-
13,237
-736
3,634
20,090
-
Other working capital
160,930
145,337
65,147
70,538
23,411
-
Other non-cash items
13,468
11,399
466
219
-
-
Net cash provided by operating activities
198,412
183,503
89,181
97,994
57,266
-
Cash flows from investing activities
Investments in property, plant and equipment
-37,482
-38,166
-24,034
-27,456
-33,855
-
Acquisitions, net
-
-506,406
0
0
-
-
Purchases of investments
-157,103
-144,556
-35,761
-17,375
-13,557
-
Sales/maturities of investments
72,055
38,622
27,969
18,771
12,411
-
Other investing activities
-
1,390
-1,372
-2,612
-1,414
-
Net cash used for investing activities
-627,546
-649,116
-32,777
-28,672
-36,415
-
Cash flows from financing activities
Debt repayment
-317,788
-318,658
-1,781
-37,901
-8,401
-
Common stock issued
-
-
-
-
0
18,298
Common stock repurchased
-50,129
-58,144
-39,909
-28,873
-24,425
-
Other financing activities
-
-25,079
-407
-56,169
-106
-
Net cash used provided by (used for) financing activities
454,062
454,093
-26,439
-37,018
-2,246
-
Net change in cash
24,533
-11,802
29,745
32,081
18,957
-
Cash at beginning of period
176,850
156,333
126,588
94,507
75,550
-
Cash at end of period
201,778
144,531
156,333
126,588
94,507
-
Free cash flow
Operating cash flow
198,412
183,503
89,181
97,994
57,266
-
Capital expenditure
-37,482
-38,166
-24,034
-27,456
-33,855
-
Free cash flow
160,930
145,337
65,147
70,538
23,411
-